DK2045244T3 - Hidtil ukendt krystal af substitueret phenylalkansyre og fremstillingsfremgangsmåde - Google Patents
Hidtil ukendt krystal af substitueret phenylalkansyre og fremstillingsfremgangsmådeInfo
- Publication number
- DK2045244T3 DK2045244T3 DK07790690.7T DK07790690T DK2045244T3 DK 2045244 T3 DK2045244 T3 DK 2045244T3 DK 07790690 T DK07790690 T DK 07790690T DK 2045244 T3 DK2045244 T3 DK 2045244T3
- Authority
- DK
- Denmark
- Prior art keywords
- hitherto
- crystal
- preparation
- phenylalkanoic acid
- substituted phenylalkanoic
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006197637 | 2006-07-20 | ||
| PCT/JP2007/063896 WO2008010448A1 (en) | 2006-07-20 | 2007-07-12 | Novel crystal of substituted phenylalkanoic acid and production process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2045244T3 true DK2045244T3 (da) | 2013-04-15 |
Family
ID=38956781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07790690.7T DK2045244T3 (da) | 2006-07-20 | 2007-07-12 | Hidtil ukendt krystal af substitueret phenylalkansyre og fremstillingsfremgangsmåde |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US7560478B2 (da) |
| EP (2) | EP2045244B1 (da) |
| JP (2) | JP5137834B2 (da) |
| KR (3) | KR101322116B1 (da) |
| CN (2) | CN102690234B (da) |
| AU (2) | AU2007274477B2 (da) |
| CA (3) | CA2659471C (da) |
| DK (1) | DK2045244T3 (da) |
| ES (1) | ES2402782T3 (da) |
| MX (1) | MX2009000448A (da) |
| PT (1) | PT2045244E (da) |
| WO (1) | WO2008010448A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010007632A (es) | 2008-01-18 | 2010-08-03 | Asahi Kasei Pharma Corp | Composicion farmaceutica estable. |
| CN104710365A (zh) | 2008-04-28 | 2015-06-17 | 旭化成制药株式会社 | 苯丙酸衍生物及其用途 |
| GB202011823D0 (en) * | 2020-07-30 | 2020-09-16 | Givaudan Sa | Method |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0495025A (ja) | 1990-08-08 | 1992-03-27 | Asahi Chem Ind Co Ltd | アルドースリダクターゼ阻害剤 |
| JPH0495049A (ja) | 1990-08-08 | 1992-03-27 | Asahi Chem Ind Co Ltd | ビフェニル‐5,5’‐ビス‐アルカン酸誘導体、その製造法およびその用途 |
| US6376546B1 (en) | 1997-10-14 | 2002-04-23 | Asahi Kasei Kabushiki Kaisha | Biphenyl-5-alkanoic acid derivatives and use thereof |
| WO2002020453A1 (en) | 2000-09-07 | 2002-03-14 | Kaneka Corporation | Methods for crystallization of hydroxycarboxylic acids |
| WO2003026572A2 (en) | 2001-09-26 | 2003-04-03 | Merck & Co., Inc. | Crystalline forms of ertapenem sodium |
| ITRM20020016A1 (it) | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza |
| DE60325830D1 (de) * | 2002-02-21 | 2009-03-05 | Asahi Kasei Pharma Corp | Substituiertes phenylalkansäurederivat und dessen verwendung |
| US6867320B2 (en) | 2002-02-21 | 2005-03-15 | Asahi Kasei Pharma Corporation | Substituted phenylalkanoic acid derivatives and use thereof |
| CA2535665A1 (en) * | 2003-08-14 | 2005-02-24 | Asahi Kasei Pharma Corporation | Substituted arylalkanoic acid derivative and use thereof |
| IL175718A0 (en) | 2005-05-18 | 2007-08-19 | Chemagis Ltd | Novel processes for preparing crystalline telmisartan form a by crystallization from dmf |
-
2007
- 2007-07-12 JP JP2008525842A patent/JP5137834B2/ja not_active Expired - Fee Related
- 2007-07-12 MX MX2009000448A patent/MX2009000448A/es active IP Right Grant
- 2007-07-12 PT PT77906907T patent/PT2045244E/pt unknown
- 2007-07-12 CN CN201210179354.8A patent/CN102690234B/zh not_active Expired - Fee Related
- 2007-07-12 KR KR1020087025075A patent/KR101322116B1/ko not_active Expired - Fee Related
- 2007-07-12 CA CA2659471A patent/CA2659471C/en not_active Expired - Fee Related
- 2007-07-12 AU AU2007274477A patent/AU2007274477B2/en not_active Ceased
- 2007-07-12 WO PCT/JP2007/063896 patent/WO2008010448A1/ja not_active Ceased
- 2007-07-12 ES ES07790690T patent/ES2402782T3/es active Active
- 2007-07-12 CN CN2007800270808A patent/CN101490012B/zh not_active Expired - Fee Related
- 2007-07-12 EP EP07790690A patent/EP2045244B1/en not_active Not-in-force
- 2007-07-12 CA CA2820931A patent/CA2820931C/en not_active Expired - Fee Related
- 2007-07-12 DK DK07790690.7T patent/DK2045244T3/da active
- 2007-07-12 KR KR1020137023629A patent/KR101440255B1/ko not_active Expired - Fee Related
- 2007-07-12 CA CA2773177A patent/CA2773177C/en not_active Expired - Fee Related
- 2007-07-12 EP EP13001575.3A patent/EP2620431A1/en not_active Withdrawn
- 2007-07-12 KR KR1020127015425A patent/KR20120084790A/ko not_active Ceased
- 2007-07-19 US US11/826,999 patent/US7560478B2/en not_active Expired - Fee Related
-
2009
- 2009-06-12 US US12/483,814 patent/US7754752B2/en not_active Expired - Fee Related
-
2010
- 2010-05-26 US US12/788,061 patent/US7838546B2/en not_active Expired - Fee Related
- 2010-10-05 US US12/898,367 patent/US7935720B2/en not_active Expired - Fee Related
-
2011
- 2011-02-01 AU AU2011200408A patent/AU2011200408B2/en not_active Ceased
-
2012
- 2012-10-04 JP JP2012222039A patent/JP5550696B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2211837T3 (da) | Ikke-vandig topikal opløsning af diclofenac og fremgangsmåde til fremstilling deraf | |
| DK2081669T3 (da) | Fremgangsmåde og anordning til fremstilling af granulater | |
| DK1773764T3 (da) | Kontinuerlig fremgangsmåde til on-site og on-demand fremstilling af en vandig pereddikesyre | |
| DK2840131T3 (da) | Fremstilling af fedtsyrer og derivater deraf | |
| DK2475372T4 (da) | Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse | |
| DK2231606T3 (da) | Fremgangsmåder til fremstilling af cycloalkylcarboxamidopyridinbenzoesyrer | |
| DK2183263T3 (da) | Fremgangsmåder og forbindelser anvendelige til fremstilling af natriumglucose-cotransportør-2-inhibitorer | |
| DK2102398T3 (da) | Fremgangsmåde til fremstilling af en ankelsok og ankelsok opnået derved | |
| DK1831154T3 (da) | Fremstilling af pregabalin og relaterede forbindelser | |
| DK2234957T3 (da) | Blandinger af diisononylestere af terephthalsyre, fremgangsmåde til fremstilling heraf og anvendelse heraf | |
| DK2048941T3 (da) | Fremgangsmåde til opdræt af rovmider | |
| DK2049672T3 (da) | Fremgangsmåde til fremstilling af bioethanol og andre fermenteringsprodukter | |
| DK1976868T3 (da) | Edderkoppesilke-proteiner og fremgangsmåde til fremstilling af edderkoppesilke-proteiner | |
| DK2316010T3 (da) | Vævskassette og fremgangsmåde til fremstilling af vævsprøver | |
| DK2019090T3 (da) | Substitueret beta-phenyl-alfa-hydroxypropansyre, fremgangsmåde til syntese og anvendelse deraf | |
| DK1857607T3 (da) | Fastgørelseselement og fremgangmåde til fastgørelse af isoleringsmaterialeplader | |
| DK2445912T3 (da) | Ny forbindelse anvendelig til behandlingen af degenerative og inflammatoriske sygdomme | |
| EP2168007A4 (en) | REFLECTIVE VISOR AND METHOD FOR THE PRODUCTION THEREOF | |
| DK2340236T3 (da) | Fremgangsmåde og anlæg til fremstilling af cementklinker | |
| DK2346765T3 (da) | Indretning og fremgangsmåde til samling af flade genstande | |
| DK2307445T3 (da) | Fremgangsmåde til fremstilling af caspofungin og mellemforbindelser heraf | |
| DK1890996T3 (da) | Krystallinske faste former af tigecyclin og fremgangsmåder til fremstilling af dette | |
| DK1745136T3 (da) | Fremgangsmåde til enzymatisk fremstilling af (S)-3-cyano-5-methylhexansyre | |
| DK1999133T3 (da) | Fremgangsmåde til fremstilling af HIV-proteaseinhibitorer | |
| DK2215050T3 (da) | Fremgangsmåde til fremstilling af 2-hydroxy-5-phenylalkylaminobenzoesyrederivater og salte deraf |